Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized, multicenter, active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy

被引：0
|
作者：
Igor Bondarenko
Oleg A Gladkov
Reiner Elsaesser
Anton Buchner
Peter Bias
机构：
[1] State Medical Academy,Dnipropetrovsk
[2] Chelyabinsk Regional Clinical Oncology Center,undefined
[3] Teva Ratiopharm,undefined
来源：
BMC Cancer | / 13卷
关键词：
Neutropenia; Febrile neutropenia; Breast cancer; Recombinant granulocyte-colony stimulating factor; Lipegfilgrastim; Pegfilgrastim;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study
    Philippe A. Cassier
    Sylvie Chabaud
    Véronique Trillet-Lenoir
    Pierre-Yves Peaud
    Jean-Dominique Tigaud
    Hervé Cure
    Hubert Orfeuvre
    Bruno Salles
    Claude Martin
    Jean-Philippe Jacquin
    Cecile Agostini
    Jean-Paul Guastalla
    David Pérol
    Thomas Bachelot
    Breast Cancer Research and Treatment, 2008, 109 : 343 - 350
  • [42] Safety and efficacy of dicarbamin in patients with early breast cancer receving DAC (docetaxel, doxorubicin, cyclophosphamide) chemotherapy in adjuvant setting
    Kopp, Mikhail V.
    Koroleva, Irina
    Mochalova, Anastasia
    Shaplygin, Leonid
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] A randomized, double-blind, active control, multicenter, dose-finding study of lipegfilgrastim (XM22) in breast cancer patients receiving myelosuppressive therapy
    Buchner, Anton
    Elsaesser, Reiner
    Bias, Peter
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 148 (01) : 107 - 116
  • [44] Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: Safety data from the multicentre phase 3 randomised ELDA trial
    Nuzzo, Francesco
    Morabito, Alessandro
    De Maio, Ermelinda
    Di Rella, Francesca
    Gravina, Adriano
    Labonia, Vincenzo
    Landi, Gabriella
    Pacilio, Carmen
    Piccirillo, Maria Carmela
    Rossi, Emanuela
    D'Aiuto, Giuseppe
    Thomas, Renato
    Gori, Stefania
    Colozza, Mariantonietta
    De Placido, Sabino
    Lauria, Rossella
    Signoriello, Giuseppe
    Gallo, Ciro
    Perrone, Francesco
    de Matteis, Andrea
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 66 (02) : 171 - 180
  • [45] efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial (vol 7, 482, 2019)
    Xu, Fengrui
    Zhang, Yang
    Miao, Zhanhui
    Zeng, Xiaohua
    Wu, Biao
    Cai, Li
    Liu, Jinping
    Wang, Shusen
    Hu, Xichun
    Zheng, Wenbo
    Chen, Zhiyue
    Yang, Qing
    Jiang, Zefei
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (10)
  • [46] Safety and efficacy of first-line epirubicin-docetaxel (ED) versus epirubicin-cyclophosphamide (EC): A multicenter randomized phase III trial in metastatic breast cancer
    Blohmer, JU
    Hauschild, M
    Hilfrich, J
    Kleine-Tebbe, A
    Kuemmel, S
    Lichtenegger, W
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 34S - 34S
  • [47] Effects of Auricular Acupressure on Constipation in Patients With Breast Cancer Receiving Chemotherapy: A Randomized Control Trial
    Shin, Jeongran
    Park, Hyojung
    WESTERN JOURNAL OF NURSING RESEARCH, 2018, 40 (01) : 67 - 83
  • [48] Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: results of a randomized, double-blind phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving chemotherapy
    Zsuzsanna Kahan
    Daniela Grecea
    Martin Smakal
    Sergei Tjulandin
    Igor Bondarenko
    Luca Perjesi
    Andras Illes
    Karoly Horvat-Karajz
    Ildiko Aradi
    BMC Cancer, 19
  • [49] Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: results of a randomized, double-blind phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving chemotherapy
    Kahan, Zsuzsanna
    Grecea, Daniela
    Smakal, Martin
    Tjulandin, Sergei
    Bondarenko, Igor
    Perjesi, Luca
    Illes, Andras
    Horvat-Karajz, Karoly
    Aradi, Ildiko
    BMC CANCER, 2019, 19
  • [50] Primary chemotherapy with gemcitabine, liposomal doxorubicin and docetaxel in patients with locally advanced breast cancer: results of a phase I trial
    Schmid, P
    Krocker, J
    Schulz, CO
    Michniewicz, K
    Dieing, A
    Eggemann, H
    Heilmann, V
    Blohmer, JU
    Sezer, O
    Elling, D
    Possinger, K
    ANTI-CANCER DRUGS, 2005, 16 (01) : 21 - 29
12345